Watson’s cognitive computing capabilities will enable clinicians, including CVS Health practitioners, to tap into large amounts of data, advancing care management programs and services.
“The capabilities of the IBM Watson Health Cloud, when coupled with CVS Health’s insights into medication utilization and patient behavior, could prove transformative for the industry,” Mike Rhodin, senior vice president for IBM Watson said in a statement. “Improving care for people with chronic conditions supports IBM’s commitment to make big plays that advance the health and well-being of the global community. Through the recent acquisitions of Phytel, Explorys and Curam we also bring extraordinary capabilities in patient engagement and population health, enabling us to deliver a powerful solution that supports individuals wherever they are, whenever they need it.”
The joint CVS Health/IBM Watson Health solution will help to predict when individuals are at risk for declining health and encourage them to adopt safe and healthy behaviors. This includes patients with chronic diseases such as hypertension, heart disease, diabetes and obesity. The technology will be capable of encouraging adherence to prescribed medicines and healthy lifestyle regimens, creating customized engagement programs and suggesting appropriate use of primary care and outpatient providers.
More articles on health IT:
DoD picks Cerner, Leidos, Accenture team for EHR modernization contract
11 most interesting developments in health IT this year
4 thoughts on Epic from healthcare leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.